Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
about
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosisAutoimmune liver serology: current diagnostic and clinical challengesApotopes and the biliary specificity of primary biliary cirrhosisXenobiotics and loss of tolerance in primary biliary cholangitisDeficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern ChinaPrimary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patientsDeletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisLiver immunology.Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosisAnti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis.Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis.Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosisPopular and unpopular infectious agents linked to primary biliary cirrhosis.Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosisMolecular diagnostic testing for primary biliary cholangitis.Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?Enzyme inhibition assay for pyruvate dehydrogenase complex: clinical utility for the diagnosis of primary biliary cirrhosis.Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisEnvironment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapyLoss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis.Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complexAdoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics.Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation.Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis.Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance.Molecular biology and the diagnosis and treatment of liver diseases.The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis.Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients.VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC.Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
P2860
Q24634370-E594BC37-2952-43DB-A2E5-7541855B51DAQ24644140-A8A49805-57D3-454D-9469-592A5F7BCB4FQ24646460-9269D8D4-2BA8-46AE-9B9D-D5E785D1B9EAQ26772312-7940830A-7364-4031-A23A-916CB8E82371Q30437183-CE05D3A7-682D-4A44-A08D-59043DE09092Q33683969-F6DD3B52-782F-44C2-A41F-F0BB700BED55Q33912324-EFB1511E-B789-4BA2-8AD5-B83E559FB2C5Q34116480-11A3BEAD-0115-4915-BBB4-2439412D4A65Q34359990-C6957944-D1BB-4E32-807D-C4F41ADCADD6Q34457114-055A619D-DDFF-452C-B609-BC3D88124A3DQ35008069-5E271327-1AD8-485A-8632-27687CA3DBAAQ35119479-109C930F-91E1-419D-8E5B-BDED27F67CF3Q35249154-F4E04F49-F493-4578-9807-9FB8B9F2FCFCQ35309882-08743FD3-7539-4077-85A6-5D511F2B9C07Q35823397-E2EBBFB6-32AE-4769-A733-6934D0B49AB7Q36086498-66B0968A-E169-4843-BE69-EC6D1725CD8EQ36179395-11E1CD47-827D-4ADE-9CD1-E23ACE5FD6BFQ36301142-A954633E-84AE-4463-8496-F77D1A1C26EAQ36373258-F0FBCC0D-A6B0-4F1F-8FA6-FD9DE03A8D9FQ36696219-56C86ACB-372F-4BDA-8DD6-C0700ADD7723Q36755979-7A737E7C-7C8C-41E5-B600-54B2775971BBQ36791956-3F5738FE-DF12-495C-B1A8-8983ABE7265FQ37120134-27089EEA-EB19-4CD2-9CDA-3465F47FB2A0Q37135580-7E1A5AEF-3802-4F97-8322-47C26ABF90E2Q37138065-3F6E0E74-D336-4BB7-B066-2222B7642399Q37358583-F229B979-60AB-4012-B451-DD80A0D25777Q37824300-90778A30-D2C3-48BD-ADD9-CE9F480B4142Q38017976-D05A3A82-F778-4404-9A74-1A3A79DCEEE9Q38067132-EFCC9C08-404A-479C-853C-7993901752EBQ38355697-AF9124A9-D9B1-408D-8C50-D93C4EB67AE8Q38565478-735BA469-122D-4A84-AA94-71BFE5FCAD22Q38805577-C83C180F-9B8A-4075-8579-8F3EE360AA8BQ38994830-B8B6547A-F74D-4368-B592-148E6F6605C8Q39003378-E2BA8496-F9D2-4605-A083-88389BD62012Q41643144-8C9AE9CE-1157-4BE3-AC20-C3D61986C659Q43073138-D301921C-B240-47B9-9639-AE2B1DACAF6BQ43425290-2F78ED36-1841-4EE3-B2F0-F59BBBBC6A37Q43608312-4D2E8541-F7F9-49C0-AE86-964476601E47Q46071293-8E024AFF-44C8-4018-823D-4A0F275C43E3Q46191599-D92E15F6-66EF-4616-9686-1C346B764410
P2860
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Use of a designer triple expre ...... imitochondrial autoantibodies.
@en
type
label
Use of a designer triple expre ...... imitochondrial autoantibodies.
@en
prefLabel
Use of a designer triple expre ...... imitochondrial autoantibodies.
@en
P2093
P356
P1433
P1476
Use of a designer triple expre ...... imitochondrial autoantibodies.
@en
P2093
P304
P356
10.1002/HEP.510240117
P407
P577
1996-07-01T00:00:00Z